Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Arthritis & Rheumatology (Hoboken, N.J.)|July 2, 2020
Taurine Metabolism Aggravates the Progression of Lupus by Promoting the Function of Plasmacytoid Dendritic CellsJun Li, Huihua Ding, Yao Meng, et al.
Theranostics|April 30, 2025
PD-1 activation mitigates lupus nephritis by suppressing hyperactive and heterogeneous PD-1+CD8+ T cellsJun Deng, Junling Zhu, Xiaoyue Jiang, et al.
Frontiers of Medicine|April 3, 2023
Control of lupus activity during pregnancy via the engagement of IgG sialylation: novel crosstalk between IgG sialylation and pDC functionsYou Wang, Sihan Lin, Jiayue Wu, et al.
Frontiers in Immunology|July 7, 2025
Rituximab as the first-line treatment in newly diagnosed systemic lupus erythematosusHaiting Wang, Liling Zhao, Shaoying Yang, et al.
Annals of the Rheumatic Diseases|September 12, 2025
IL-2 signalling sustains pathogenic age-associated B cell homeostasis in lupusXiaxia Han, Yang Jiang, Shuangshuang Gu, et al.
The Journal of Clinical Investigation|August 15, 2024
Autocrine VEGF-B signaling maintains lipid synthesis and mitochondrial fitness to support T cell immune responsesJianli He, Yalan Chen, Huihua Ding, et al.
Frontiers in Immunology|January 1, 2026
Correction: Obinutuzumab in systemic lupus erythematosus: a real-world experienceChunmei Wu, Yinglu Wang, Shenshen Chen, et al.
Arthritis Research & Therapy|March 29, 2022
Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritisHuihua Ding, Yiwei Shen, Cheng Lin, et al.
Frontiers in Immunology|December 5, 2025
Obinutuzumab in systemic lupus erythematosus: a real-world experienceChunmei Wu, Yinglu Wang, Shenshen Chen, et al.
Frontiers in Immunology|July 25, 2022
Targeting Multiple End Organs in Lupus and Other Systemic Rheumatic Diseases by Inhibiting Bruton's Tyrosine KinaseYong Du, Ling Lei, Huihua Ding, et al.
Pageof 7